Location: Home
  • search
  • go
  • Relate News
  • 1/14/2026Chinese Scientists Unveil Novel Intratumoral Vaccine
  • 1/13/2026China Weighs Approval of Russian Cancer Vaccine
  • 1/12/2026SciNeuro and Novartis Forge $1.5B Collaboration on Next-Gen Alzheimer'...
  • 1/8/2026Alumis Reports Positive Phase 3 Results for Envudeucitinib in Plaque P...
  • 1/8/2026Sinovac Secures Exclusive 2026 Influenza Vaccine Supply Contract with ...
  • 1/1/2026China's NMPA Issues Updated Bevacizumab Labeling Requirements
  • 12/30/2025Recbio's Files NDA for Shingles Vaccine REC610 China
  • 12/30/2025Ultra-Low Flu Shot Prices Highlight Intensifying Pressure on China’s ...
  • 12/30/2025Suzhou Launches China's First Nuclear Medicine Demonstration Base
  • 12/27/2025China Approves Novo Nordisk's Sogroya for Pediatric Growth Hormone Def...
  • 12/27/2025Chengdu Maxvax Biotech Completes D+ Financing Round
  • 12/27/2025Telix Advances Regulatory Efforts with Positive China Phase 3 Data
  • 12/27/2025China Leads Globally in mRNA-Based Therapeutic Vaccine Development for...
  • 12/17/2025China's New Drug Commercial Insurance Scheme Offers Hope for Patients ...
  • 12/16/2025GeneScience Signs Up to $1.37B Global Licensing Deal for TSHR Antibody...
  • 12/15/2025Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
  • 12/11/2025China Pushes Private Insurance to Cover High-Cost Innovative Drugs as ...
  • 12/10/2025China Launches First Commercial Insurance Drug List, Spotlighting High...
  • 12/10/2025Dizal Showcases Broad ASH25 Data for Golidocitinib and Birelentinib
  • 12/10/2025China's Human Vaccine Market Set for Steady Long-Term Expansion
  • 12/5/2025ARCH, Lilly Asia Ventures Return to Back US–China Startup SciNeuro wi...
  • 12/5/2025China Issues Revised Guideline on Grading Adverse Events in Vaccine Cl...
  • 11/27/2025GlobalData: Ivonescimab Poised to Transform China's TNBC Market
  • 11/27/2025Olymvax Files for Hong Kong Listing as Vaccine Pipeline Expands
  • 11/25/2025Pfizer's Hympavzi (Marstacimab) Gains NMPA Approval in China
  • 11/25/2025Kelun Reports Positive Phase 2 Results for Sac-TMT Combined with KEYTR...
  • 11/21/2025Xiangxue Expands Into In Vivo TCR-T Therapy Through New Partnership
  • 11/18/2025Sinovac Expands Flu Vaccine Use to Infants from 6 Months
  • 11/18/2025CDE Issues the Technical Guidelines for Clinical Trials of Multivalent...
  • 11/14/2025NMPA Clears IND for GenSci's In-House Bispecific ADC GenSci140
  • Page:1/76 Total number of articles:2252: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group